Article
Promoter methylation of human mutL homolog 1 and colorectal cancer risk: A meta-analysis.
Journal of cancer research and therapeutics - 1 Jan 2018
Shi Bian, Chu Junfeng, Gao Qilong, Tian Tongde
Abstract excerpt
AIMS: Several studies suggested that promoter methylation of human mutL homolog 1 (hMLH1) was associated with the risk of colorectal cancer (CRC). However, other studies did not indicate the same results. To derive a more comprehensive estimation of the association between hMLH1 methylation and CRC risk, we conducted a meta-analysis. MATERIALS AND METHODS: We searched in the PubMed, EMBASE, and WanFang Medicine...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
